Tvardi Therapeutics, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Imran Alibhai, with a market cap of $29.6M.
Common questions about Tvardi Therapeutics, Inc. Common Stock
Tvardi Therapeutics, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 12, 2026 before market open.
We use cookies for analytics. See our Privacy and Cookie Policy.